Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Osteosarcoma × Sunitinib × Clear all

Phase

Phase 2 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 14 Neoplasms 11 Kidney Neoplasms 5 Stomach Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Solid Tumors 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Glioblastoma 3 Gastrointestinal Stromal Tumors 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Acute 2 Glioma 2 Colorectal Neoplasms 2 Clear-cell metastatic renal cell carcinoma 2 Adenoma, Islet Cell 2 Uveal Melanoma 1 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Tongue Neoplasms 1 Thrombocytosis 1 Thoracic Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Salivary Gland Neoplasms 1 Primary Myelofibrosis 1

Interventions

Cyclophosphamide 12 fludarabine 5 Methotrexate 5 Leucovorin 5 Granulocyte Colony-Stimulating Factor 5 Gemcitabine 5 Filgrastim 5 Zoledronic Acid 4 Temozolomide 4 Mesna 4 Ifosfamide 4 Etoposide 4 Cisplatin 4 Carboplatin 4 pembrolizumab 3 fludarabine phosphate 3 Irinotecan 3 Biopsy 3 tanespimycin 2 poly ICLC 2 pegfilgrastim 2 lorukafusp alfa 2 liposomal doxorubicin 2 dinutuximab 2 cabozantinib 2 belinostat 2 Topotecan 2 Specimen Handling 2 Sirolimus 2 Magnetic Resonance Spectroscopy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03900793 2026-02-03

Losartan + Sunitinib in Treatment of Osteosarcoma

University of Colorado, Denver

Phase 1 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡